COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review
Data
2020Autor
Suri, Jasjit S.
Puvvula, Anudeep
Biswas, Mainak
Majhail, Misha
Saba, Luca
Faa, Gavino
Singh, Inder M.
Oberleitner, Ronald
Turk, Monika
Chadha, Paramjit S.
Johri, Amer M.
Sanches, J. Miguel
Khanna, Narendra N.
Viskovic, Klaudija
Mavrogeni, Sophie
Laird, John R.
Pareek, Gyan
Miner, Martin
Sobel, David W.
Balestrieri, Antonella
Sfikakis, Petros P.
Tsoulfas, George
Protogerou, Athanasios
Prasanna Misra, Durga
Agarwal, Vikas
Kitas, George D.
Ahluwalia, Puneet
Kolluri, Raghu
Teji, Jagjit
Al Maini, Mustafa
Agbakoba, Ann
Dhanjil, Surinder K.
Sockalingam, Meyypan
Saxena, Ajit
Nicolaides, Andrew
Sharma, Aditya
Rathore, Vijay
Ajuluchukwu, Janet N.A.
Fatemi, Mostafa
Alizad, Azra
Viswanathan, Vijay
Krishnan, P.K.
Naidu, Subbaram
Metadata
Mostrar registro completo
Documentos PDF
Imagenes y Videos
Resumo
Artificial intelligence (AI) has penetrated the field of medicine, particularly the field of radiology. Since
its emergence, the highly virulent coronavirus disease 2019 (COVID-19) has infected over 10 million
people, leading to over 500,000 deaths as of July 1st, 2020. Since the outbreak began, almost 28,000
articles about COVID-19 have been published (https://pubmed.ncbi.nlm.nih.gov); however, few have
explored the role of imaging and artificial intelligence in COVID-19 patients—specifically, those with
comorbidities.
This paper begins by presenting the four pathways that can lead to heart and brain injuries
following a COVID-19 infection. Our survey also offers insights into the role that imaging can play in the
treatment of comorbid patients, based on probabilities derived from COVID-19 symptom statistics. Such
symptoms include myocardial injury, hypoxia, plaque rupture, arrhythmias, venous thromboembolism,
coronary thrombosis, encephalitis, ischemia, inflammation, and lung injury. At its core, this study
considers the role of image-based AI, which can be used to characterize the tissues of a COVID-19
patient and classify the severity of their infection. Image-based AI is more important than ever as the
pandemic surges and countries worldwide grapple with limited medical resources for detection and
diagnosis.
We conclude that imaging and AI-based tissue characterization, when considered alongside
COVID-19 symptoms and their pre-test probabilities, offer a compelling solution for assessing the risk of
comorbid patients. These methods show the potential to become an integral part of tracking and
improving the healthcare system, both during the pandemic and beyond.
Palabras clave
COVID-19; Comorbidity; Pathophysiology; Heart; Brain; Lung; Imaging; Artificial intelligence; Risk assessmentLink para o recurso
https://doi.org/10.1016/j.compbiomed.2020.103960Collections
Estadísticas Google Analytics
Comments
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.